Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX · · 12 pages · English
In the deck
Earlier from Bioxyne
- Supply Agreement Secured - Central American Cannabis Markets
- Funding from SOSE to Establish UK GMP Manufacturing Facility
- BLS to Manufacture and Distribute Curaleaf International MID
- Presentation on FY2025 Quarter 1 Results
- Initial German Purchase Orders and Import Permits
Later from Bioxyne
- Appendix 4C Revised
- Presentation Results Q2 FY2026
- Half Yearly Report and Accounts
- Stronger H1 FY2026 Performance Upward Revision to Guidance
- BXN H1 FY2026 Results Presentation
Follow Bioxyne into a list and get an email when it puts out news.
Follow Bioxyne